Logo image of CLBR

COLOMBIER ACQUISITION CORP-A (CLBR) Stock Fundamental Analysis

USA - NYSE:CLBR - KYG2283U1004 - Common Stock

17.24 USD
+0.28 (+1.65%)
Last: 7/15/2025, 8:04:00 PM
16.9 USD
-0.34 (-1.97%)
After Hours: 7/15/2025, 8:04:00 PM
Fundamental Rating

2

Taking everything into account, CLBR scores 2 out of 10 in our fundamental rating. CLBR was compared to 0 industry peers in the Unkown industry. The financial health of CLBR is average, but there are quite some concerns on its profitability. CLBR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CLBR had positive earnings in the past year.
In the past year CLBR has reported a negative cash flow from operations.
Of the past 5 years CLBR 4 years were profitable.
In the past 5 years CLBR always reported negative operating cash flow.
CLBR Yearly Net Income VS EBIT VS OCF VS FCFCLBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M

1.2 Ratios

Industry RankSector Rank
ROA 2.25%
ROE 2.35%
ROIC N/A
ROA(3y)2.26%
ROA(5y)N/A
ROE(3y)2.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CLBR Yearly ROA, ROE, ROICCLBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 1 -1 2 3

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CLBR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CLBR Yearly Profit, Operating, Gross MarginsCLBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

5

2. Health

2.1 Basic Checks

CLBR has about the same amout of shares outstanding than it did 1 year ago.
CLBR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CLBR Yearly Shares OutstandingCLBR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
CLBR Yearly Total Debt VS Total AssetsCLBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 40.32 indicates that CLBR is not in any danger for bankruptcy at the moment.
There is no outstanding debt for CLBR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 40.32
ROIC/WACCN/A
WACCN/A
CLBR Yearly LT Debt VS Equity VS FCFCLBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

CLBR has a Current Ratio of 0.34. This is a bad value and indicates that CLBR is not financially healthy enough and could expect problems in meeting its short term obligations.
CLBR has a Quick Ratio of 0.34. This is a bad value and indicates that CLBR is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.34
CLBR Yearly Current Assets VS Current LiabilitesCLBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

1

3. Growth

3.1 Past

CLBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1289.74%, which is quite impressive.
CLBR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.67% yearly.
EPS 1Y (TTM)1289.74%
EPS 3Y2.67%
EPS 5YN/A
EPS Q2Q%-102.94%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 90.74, the valuation of CLBR can be described as expensive.
CLBR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.03.
Industry RankSector Rank
PE 90.74
Fwd PE N/A
CLBR Price Earnings VS Forward Price EarningsCLBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CLBR Per share dataCLBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CLBR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COLOMBIER ACQUISITION CORP-A

NYSE:CLBR (7/15/2025, 8:04:00 PM)

After market: 16.9 -0.34 (-1.97%)

17.24

+0.28 (+1.65%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-04 2025-08-04
Inst Owners78.62%
Inst Owner Change-8.8%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap543.92M
Revenue(TTM)N/A
Net Income(TTM)4.05M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 90.74
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.16
P/tB 3.16
EV/EBITDA N/A
EPS(TTM)0.19
EY1.1%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)-0.07
OCFYN/A
SpS0
BVpS5.46
TBVpS5.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 2.25%
ROE 2.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)2.26%
ROA(5y)N/A
ROE(3y)2.35%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.34
Quick Ratio 0.34
Altman-Z 40.32
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1289.74%
EPS 3Y2.67%
EPS 5YN/A
EPS Q2Q%-102.94%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-583.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-113.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-113.87%
OCF growth 3YN/A
OCF growth 5YN/A

COLOMBIER ACQUISITION CORP-A / CLBR FAQ

Can you provide the ChartMill fundamental rating for COLOMBIER ACQUISITION CORP-A?

ChartMill assigns a fundamental rating of 2 / 10 to CLBR.


What is the valuation status of COLOMBIER ACQUISITION CORP-A (CLBR) stock?

ChartMill assigns a valuation rating of 0 / 10 to COLOMBIER ACQUISITION CORP-A (CLBR). This can be considered as Overvalued.


How profitable is COLOMBIER ACQUISITION CORP-A (CLBR) stock?

COLOMBIER ACQUISITION CORP-A (CLBR) has a profitability rating of 1 / 10.


What is the financial health of COLOMBIER ACQUISITION CORP-A (CLBR) stock?

The financial health rating of COLOMBIER ACQUISITION CORP-A (CLBR) is 5 / 10.